BDX · 8-K · 20260806PR053790
Spin-off and Combination
BECTON DICKINSON & CO · 2026-08-06 · Importance 71 · Surprise 60 · No source text
BD completed the February 9, 2026 spin-off of its former Biosciences and Diagnostic Solutions business and its combination with Waters Corporation. The former business, previously reported as the Life Sciences segment, is presented as discontinued operations for all periods, and prior periods were recast to continuing operations. Nine-month separation-related items totaled $73 million before tax, including $32 million in the third quarter. BD received a $3.857 billion net distribution from the spin-off entity during the first nine months and reported a $276 million net loss from discontinued operations versus $430 million of income in the prior-year period.
Key facts
- Loss from discontinued operations, net of tax, for the three months ended June 30, 2026: $(74) million versus income of $123 million prior year (change of (159.8)%). source
- BD completed the spin-off of its former Biosciences and Diagnostic Solutions business and the combination of that business with Waters Corporation on February 9, 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | realized | -4.0% | Loss from discontinued operations, net of tax, for the three months ended June 30, 2026: $(74) million versus income of $123 million prior… |